Fibrocor is developing therapeutics based on a discovery platform for novel fibrosis targets.
Employees: 11-50
Investors 1
| Date | Name | Website |
| 18.08.2021 | BioGenerat... | biogenerat... |
Mentions in press and media 1
| Date | Title | Description |
| 17.01.2017 | Fibrocor Therapeutics Raises CDN$2.8m in Funding | Fibrocor Therapeutics, LP, a Toronto, Canada-based company focused on developing therapeutics targeting fibrotic diseases, raised CDN$2.8m (approx. $2.1m) in funding. MaRS Innovation provided the funding while Evotec AG (Frankfurt Stock Exc... |